STAT3 and arthritic joint disease: In a study of mice with CIA, it was shown that inhibitor COX2, meloxicam, can inhibit STAT3 activation and act as an arthritis inhibitor blocking the formation of osteoclasts, thereby eradicating cartilage erosion [137].